ID

22184

Beskrivning

A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD) Medicine: rosiglitazone, Condition: Alzheimer's Disease, Phase: 2, Clinical Study ID: 49653/461, Sponsor: GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1

Länk

https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1

Nyckelord

Versioner (1)
  1. 2017-05-22 2017-05-22 -
Uppladdad den

22 maj 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

  • Senaste
  • Äldsta
  • Önskad
  • Senaste
    • Senaste
    • Äldsta
    • Önskad

Inga kommentarer

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Prior Medication Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

Engelsk

Prior Medication Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

1 Formulär  
Prior Medication
Beskrivning

Prior Medication

Alias
UMLS CUI-1
C0013227
Has the patient taken any medication within 1 week PRIOR to the first dose of study medication?
Beskrivning

Pharmaceutical preparations

Datatyp

boolean

Alias
UMLS CUI [1]
C0013227
If ´YES`, please record the medications below.
Beskrivning

specification

Datatyp

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C2348235
Prior Medication
Beskrivning

Prior Medication

Alias
UMLS CUI-1
C2826257
Drug name (Trade Name preferred)
Beskrivning

Drug name

Datatyp

text

Alias
UMLS CUI [1]
C0013227
Single Dose/ Unit (e.g. 500mg)
Beskrivning

Single dose/Unit

Datatyp

float

Måttenheter
  • mg
Alias
UMLS CUI [1,1]
C2826257
UMLS CUI [1,2]
C1960417
mg
Frequency of this Dose (e.g. BID PRN)
Beskrivning

Frequency

Datatyp

text

Alias
UMLS CUI [1]
C3476109
Route
Beskrivning

Route

Datatyp

text

Alias
UMLS CUI [1]
C0013153
Indication
Beskrivning

Indication

Datatyp

text

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0013227
End Date
Beskrivning

End Date

Datatyp

date

Måttenheter
  • Day Month Year
Alias
UMLS CUI [1]
C1531784
Day Month Year
Continuing at end of
Beskrivning

Continuing

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C1553904
Tillbaka till toppen

Similar models

Prior Medication Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Prior Medication
C0013227 (UMLS CUI-1)
Pharmaceutical preparations
Item
Has the patient taken any medication within 1 week PRIOR to the first dose of study medication?
boolean
C0013227 (UMLS CUI [1])
specification
Item
If ´YES`, please record the medications below.
text
C0013227 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
Item Group
Prior Medication
C2826257 (UMLS CUI-1)
Drug name
Item
Drug name (Trade Name preferred)
text
C0013227 (UMLS CUI [1])
Single dose/Unit
Item
Single Dose/ Unit (e.g. 500mg)
float
C2826257 (UMLS CUI [1,1])
C1960417 (UMLS CUI [1,2])
Frequency
Item
Frequency of this Dose (e.g. BID PRN)
text
C3476109 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
Indication
Item
Indication
text
C3146298 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
End Date
Item
End Date
date
C1531784 (UMLS CUI [1])
Continuing
Item
Continuing at end of
boolean
C0087111 (UMLS CUI [1,1])
C1553904 (UMLS CUI [1,2])
Tillbaka till toppen 

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial